Conquering Diseases

Study Of An Investigational Drug For Major Depressive Disorder

Description

Seeking adults aged 18 to 64 with recurring major depressive disorder without psychotic features for a study of an investigational drug.

Overview

After an 8-week screening period participants in this study will be randomly assigned to get either the investigational drug or a placebo (looks like the drug, but contains no medicine) as a pill taken 4 times a day for up to 2 weeks. There are at least 8 site visits and up to 13 telephone calls.

What we're hoping for

We are studying how well an investigational drug works and is tolerated as compared to placebo (looks like the drug but has no medicine) on reducing the symptoms of depression in adults with major depressive disorder (MDD).

Additional Information

ClinicalTrials.gov Identifier: NCT06785012

 Principal Investigator

Anthony  Rothschild, MD

UMass Memorial Health

 Study Contact

Michelangela  Yusif

774-455-4136

Michelangela.Yusif@umassmed.edu

 Location

UMass Chan University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989